There are no established guidelines for skin cancer screening in BRCA1/2 carriers; however, the NCCN guidelines propose skin exploration annually for patients with pathogenic variants in the BRCA2 gene [13]. The gene discussed is BRCA1; the disease is skin neoplasm.